Evidence map›Paper›PMID 19109153›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.

Shana M Coley, Mandy L Ford, Samantha C Hanna, Maylene E Wagener, Allan D Kirk, Christian P Larsen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effector T Cells and Ischemia-Induced Systemic Angiogenesis in the Lung.American journal of respiratory cell and molecular biology · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shana M ColeyDepartment of Surgery, Emory Transplant Center, Emory University, Atlanta, GA 30322, USA.
Mandy L Ford
Samantha C Hanna
Maylene E Wagener
Allan D Kirk
Christian P Larsen
Emory University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Activation, Apathy, Anergy and Apoptosis in TransplantationR37AI040519 · NIAID · EMORY UNIVERSITY · PI LARSEN, CHRISTIAN P. · 2007 to 2016
$4.1M
NCATS NIH HHS UL1 TR000454NCRR NIH HHS UL1 RR025008NIAID NIH HHS R37 AI040519NIAID NIH HHS R37 AI40519-11NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

CD8 T cells are necessary for costimulation blockade-resistant rejection. However, the mechanism by which CD8 T cells mediate rejection in the absence of major costimulatory signals is poorly understood. IFN-gamma promotes CD8 T cell-mediated immune responses, but IFN-gamma-deficient mice show early graft loss despite costimulation blockade. In contrast, we found that IFN-gamma receptor knockout mice show dramatically prolonged graft survival under costimulation blockade. To investigate this paradox, we addressed the effects of IFN-gamma on T cell alloresponses in vivo independent of the effects of IFN-gamma on graft survival. We identified a donor-specific CD8 T cell breakthrough response temporally correlated with costimulation blockade-resistant rejection. Neither IFN-gamma receptor knockout recipients nor IFN-gamma-deficient recipients showed a CD8 breakthrough response. Graft death on IFN-gamma-deficient recipients despite costimulation blockade could be explained by the lack of IFN-gamma available to act on the graft. Indeed, the presence of IFN-gamma was necessary for graft survival on IFN-gamma receptor knockout recipients, as either IFN-gamma neutralization or the lack of the IFN-gamma receptor on the graft precipitated early graft loss. Thus, IFN-gamma is required both for the recipient to mount a donor-specific CD8 T cell response under costimulation blockade as well as for the graft to survive after allotransplantation.

Indexed as

AbataceptAnimalsAntibodies, MonoclonalCD40 LigandCD8-Positive T-LymphocytesFemaleGraft RejectionGraft SurvivalImmunoconjugatesImmunosuppressive AgentsInterferon-gammaInterferon gamma ReceptorLymphocyte ActivationMaleMiceMice, Inbred BALB CAbataceptAntibodies, MonoclonalCD40 LigandImmunoconjugatesImmunosuppressive AgentsInterferon-gammaInterferon gamma ReceptorReceptors, Interferon

Identifiers

PMID19109153
PMCPMC2683416
OpenAlexW1508800859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.